Amphastar Pharmaceuticals's total assets for Q4 2025 were $1.63B, a decrease of -2.22% from the previous quarter. AMPH total liabilities were $840.49M for the fiscal quarter, a -5.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.